Search Results - "Tvedten, T"

  • Showing 1 - 11 results of 11
Refine Results
  1. 1
  2. 2
  3. 3

    EPA-0513 – Methylphenidate hydrochloride modified release (mph-la) maintained efficacy over long-term in the treatment of adult attention deficit hyperactivity disorder (adhd) by Ginsberg, Y, Tvedten, T, Arngrim, T, Philipsen, A, Gandhi, P, Chen, C.W, Kumar, V, Huss, M

    Published in European psychiatry (2014)
    “…Introduction Previously, we reported the clinical efficacy of MPH-LA in adult ADHD evaluated in a 40-week, randomised, double-blind, placebo-controlled,…”
    Get full text
    Journal Article
  4. 4

    EPA-0626 – Long-term safety of methylphenidate hydrochloride modified release (MPH-LA) in the treatment of attention deficit hyperactivity disorder (ADHD) in adults by Ginsberg, Y, Tvedten, T, Arngrim, T, Philipsen, A, Gandhi, P, Chen, C.W, Kumar, V, Huss, M

    Published in European psychiatry (2014)
    “…Introduction A previous 40-week, randomised, double-blind placebo-controlled core study [comprising of dose confirmation (9-week), real-life dose optimisation…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Methylphenidate Hydrochloride Modified-Release in Adults with Attention Deficit Hyperactivity Disorder: A Randomized Double-Blind Placebo-Controlled Trial by Huss, Michael, Ginsberg, Ylva, Tvedten, Torbjorn, Arngrim, Torben, Philipsen, Alexandra, Carter, Katherine, Chen, Chien-Wei, Kumar, Vinod

    Published in Advances in therapy (01-01-2014)
    “…Introduction Treatment options for adults with attention deficit hyperactivity disorder (ADHD) are limited. The study was conducted to confirm the clinically…”
    Get full text
    Journal Article
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11